Kodiak Sciences Inc · NASDAQ:KOD
Baker Julian bought 418,323 Kodiak Sciences Inc shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 30, 2026
On Sep 28, 2026, Baker Julian (Director, 10% owner) bought 418,323 Kodiak Sciences Inc shares at an average US$83.58 for US$35M, leaving 19,515,907 shares. Filed Sep 30, 2026 (Form 4).
- Bought
- 418,323 shares
- Price
- US$83.58 average (US$79.40 to US$85.97)
- Value
- US$35M
- Holding after
- 19,515,907 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Buy | 534 | US$79.40 | 1,606,426 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 8,956 | US$79.40 | 19,130,090 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 17 | US$79.63 | 1,606,443 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 283 | US$79.63 | 19,130,373 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 884 | US$79.71 | 1,607,327 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 14,827 | US$79.71 | 19,145,200 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 404 | US$80.23 | 1,607,731 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 6,783 | US$80.23 | 19,151,983 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 61 | US$80.52 | 1,607,792 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,027 | US$80.52 | 19,153,010 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,024 | US$81.02 | 1,608,816 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 17,159 | US$81.02 | 19,170,169 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 338 | US$81.20 | 1,609,154 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 5,654 | US$81.20 | 19,175,823 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,044 | US$81.31 | 1,610,198 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 17,490 | US$81.31 | 19,193,313 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,672 | US$81.82 | 1,611,870 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 28,028 | US$81.82 | 19,221,341 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 39 | US$81.92 | 1,611,909 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 651 | US$81.92 | 19,221,992 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 101 | US$82.68 | 1,612,010 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,699 | US$82.68 | 19,223,691 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 1,167 | US$83.16 | 1,613,177 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 19,554 | US$83.16 | 19,243,245 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 7,390 | US$83.95 | 1,620,567 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 123,888 | US$83.95 | 19,367,133 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 6,553 | US$84.85 | 1,627,120 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 109,842 | US$84.85 | 19,476,975 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 2,322 | US$85.97 | 1,629,442 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 38,932 | US$85.97 | 19,515,907 | Indirect |
Source
Related
- Kodiak Sciences Inc
- Baker Julian
- Kodiak Sciences Inc shareholders
- Form 4 · 667, L.P. · Sep 30, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 30, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026